A61P 11 - Drugs for disorders of the respiratory system

Patents for A61P 11 - Drugs for disorders of the respiratory system (87,767)
11/2001
11/22/2001	WO2001060312A8 Device for calculating elixir doses appropriate for a patient's weight
11/22/2001	WO2001046128A3 Tryptase inhibitors
11/22/2001	WO2001042246A3 PYRROLO[2,3-d]PYRIMIDINE COMPOUNDS
11/22/2001	WO2001036462A3 Protein c derivatives
11/22/2001	WO2001030781A3 INHIBITORS OF αLβ2 MEDIATED CELL ADHESION
11/22/2001	WO2001025239A3 Oxazinoquinolones useful for the treatment of viral infections
11/22/2001	US20010044937 Transgenic intracytoplasmic sperm injection, retroviral gene transfer, intracytoplasmic nuclear injection, and pronuclear injection; useful as models for human disease/diagnosis, assessing safety and efficiency of drug and gene therapy
11/22/2001	US20010044544 Useful as high energy oxidizing agents in explosive and propellant formulations, and drugs for vasodilation
11/22/2001	US20010044538 Mitogen-activated protein (MAP) kinase; treating inflammatory diseases; compounds such as 3-(4-fluorophenyl)-1-hydroxy-2-(pyridin-4-yl)-1H-pyrrolo(3,2-b)pyridine
11/22/2001	US20010044468 Reduced in the body to produce a benzamidine; nontoxic
11/22/2001	US20010044442 Dimethoxy quinazolines for treating diabetes
11/22/2001	US20010043906 Aerosolizing a solution of aqueous gamma-interferon, a stabilizer and a dispersant by forcing the solution through openings in a plate and delivering the droplets to a patient's respiratory tract; storage stability
11/22/2001	DE10020667A1 Neue Benzoxazin- und Benzothiazin-Derivate und deren Verwendung in Arzneimitteln New benzoxazine and benzothiazine derivatives and their use in medicaments
11/22/2001	CA2409813A1 Compositions and methods for treatment of mucosal infections
11/22/2001	CA2409740A1 Novel aryl, alkenyl, and alkynyl 4-dedimethylaminotetracycline desrivatives
11/22/2001	CA2409699A1 Novel polymorph v of torasemide
11/22/2001	CA2409225A1 Tricyclic pyrazole derivatives
11/22/2001	CA2409116A1 Substituted thioacetamides
11/22/2001	CA2409068A1 Novel dual oxidases as mitogenic and endocrine regulators
11/22/2001	CA2409035A1 Hydroxamic acid derivatives
11/22/2001	CA2408830A1 Treatment of human papillomavirus (hpv)-infected cells
11/22/2001	CA2408745A1 Anti-angiogenic polypeptides
11/22/2001	CA2407469A1 Combination therapy using cox-2 selective inhibitor and thromboxane inhibitor and compositions therefor
11/22/2001	CA2407258A1 Pharmaceutically active piperidine derivatives, in particular as modulators of chemokine receptor activity
11/22/2001	CA2406013A1 Treatment of autoimmune, proliferative and inflammatory diseases with compositions of non-ionic copolymers
11/21/2001	EP1156111A1 Chimeric arterivirus-like particles
11/21/2001	EP1156110A2 G-protein coupled receptor (HFGAN72Y)
11/21/2001	EP1156049A1 Substituted heterocyclic compounds, their process of preparation and pharmaceutical compositions containing them
11/21/2001	EP1155691A2 Anti-angiogenic compositions and methods of use
11/21/2001	EP1155690A2 Anti-angiogenic compositions and method of use
11/21/2001	EP1155689A2 Anti-angiogenic compositions and methods of use
11/21/2001	EP1155019A1 Substituted porphyrins
11/21/2001	EP1155011A1 Di- and tripeptide nitrile derivatives as inhibitors of cathepsin l and cathepsin s
11/21/2001	EP1155010A1 Acetamido acetonitrile derivatives as inhibitors of cathepsin l and/or cathepsin s
11/21/2001	EP1155000A1 2-aminopyridines containing fused ring substituents
11/21/2001	EP1154993A1 Thioamide derivatives
11/21/2001	EP1154988A1 Mevinolin derivatives
11/21/2001	EP1154987A1 Phenylalaninol derivatives
11/21/2001	EP1154786A2 Methods and compositions for altering mucus secretion
11/21/2001	EP1154764A1 Epoxide hydrolase complexes and methods therewith
11/21/2001	EP1154762A1 Pharmaceutical capsule compositions containing loratadine and pseudoephedrine
11/21/2001	EP0958277B1 Nitric oxide synthase inhibitors
11/21/2001	EP0914319B1 Diarylalkyl cyclic diamine derivatives as chemokine receptor antagonists
11/21/2001	EP0836645A4 Dry powder formulations of polynucleotide complexes
11/21/2001	EP0832082B1 N-heteroaryl-pyridinesulfonamide derivatives and their use as endothelin antagonists
11/21/2001	CN1323309A Phenyl yanthine derivatives
11/21/2001	CN1323301A Diarylbenzopyran derivatives as cyclooxygenase-2 inhibitors
11/21/2001	CN1323295A AZA-bicycles which modulate the inhibition of cell adhesion
11/21/2001	CN1323216A Use of recombinant human uteroglobin in treatment of inflammatory and fibrotic conditions
11/21/2001	CN1323211A New pharmaceutical uses for NOS inhibitors
11/21/2001	CN1323209A Use of piperidines and/or piperazines as inhibitors of p38-alpha kinase
11/21/2001	CN1323201A Extended release buccal bioadhesive tablet
11/21/2001	CN1323186A Two chamber cartridge for atomizers
11/21/2001	CN1322571A Pharynygitis treating Chinese medicine and its preparation
11/21/2001	CN1322569A Method of preparing Qingjiangpian tablets for clearing heat and detoxicating
11/21/2001	CN1322566A Medicine for treating stomatopathy and throat disease
11/21/2001	CN1322538A Oral Chinese medicine for treating bronchial asthma and chronic bronchitis
11/21/2001	CN1322528A Rhinitis treating medicine
11/21/2001	CN1074927C Active medical component of 'Duanshepiju' its extraction process and medicine containing the same
11/20/2001	US6320052 Crystalline precursors of 1-(((1(r)-(3-(2-(7-chloro-2-quino lynyl)ethenyl)phenyl)-3-(2-hydroxy-1-methyl-ethyl)phenyl) propyl)thio)methyl)cyclopropylacetic acid
11/20/2001	US6319920 Muscarinic receptor antagonist used in gastrointestinal, genitourinary tract, respiratory tract, cardiovascular system, central nervous system disorders and in anesthesiology and ophthalmology
11/20/2001	US6319917 Acylaminoalkenylene-amide derivatives as NK1 and NK2 antagonists
11/20/2001	US6319686 Nucleotide sequences coding binding protein; for use as diagnostic, drug design and therapeutic tools
11/20/2001	US6319513 Oral liquid mucoadhesive compounds
11/20/2001	CA2017851C Micronised biodegradable particles, process for preparing them and the use thereof
11/15/2001	WO2001085980A2 Enzymatic assays for screening anti-cancer agents
11/15/2001	WO2001085942A2 Cytoskeleton-associated proteins
11/15/2001	WO2001085935A2 Endothelial differentiation gene 6-like g protein coupled receptor
11/15/2001	WO2001085779A2 Protein complexes and assays for screening anti-cancer agents
11/15/2001	WO2001085766A2 Novel eosinophil cationic proteins used in the treatment of asthmatic and allergic disorders
11/15/2001	WO2001085762A2 Cancer diagnosis and assays for screening anti-cancer agents
11/15/2001	WO2001085755A1 2-substituted pregna-1, 3, 5 (10) -triene and chola-1, 3, 5 (10)-triene derivatives and their biological activity
11/15/2001	WO2001085696A1 Butenoic acids derivatives and their use in the treatment of rhinitis
11/15/2001	WO2001085677A1 Amino acid derivatives and their use as medicines
11/15/2001	WO2001085256A2 Critical illness neuropathy
11/15/2001	WO2001085204A2 Therapeutic method and composition utilizing antigen-antibody complexation and presentation by dendritic cells
11/15/2001	WO2001085203A2 Therapeutic method and composition utilizing antigen-antibody complexation and presentation by dendritic cells
11/15/2001	WO2001085194A1 Method and composition for the treatment of angiogenesis
11/15/2001	WO2001085174A1 Formulations containing a glucocorticoid drug for the treatment of bronchopulmonary diseases
11/15/2001	WO2001085160A1 Peptide deformylase inhibitors
11/15/2001	WO2001085148A2 Packaging regimen of pseudoephedrine hydrochloride and fexofenadine hydrocloride
11/15/2001	WO2001085146A1 Pharmaceutical compounds for treating copd
11/15/2001	WO2001085144A2 Use of substituted acryloyl distamycin derivatives in the treatment of tumors associated with high levels of glutathione
11/15/2001	WO2001085097A2 Medicament container with same side airflow inlet and outlet and method of use
11/15/2001	WO2001085096A2 Mast cell regulation
11/15/2001	WO2001036001A3 Interferon gamma conjugates
11/15/2001	WO2001034601A3 Imidazopyridine derivatives as phosphodiesterase vii inhibitors
11/15/2001	WO2001001995A3 Method for treatment of asthma syndrome
11/15/2001	US20010041799 Diephenyl carbocyclic thioamide derivatives
11/15/2001	US20010041726 Nitrosated and nitrosylated cyclooxygenase-2 inhibitors, compositions and methods of use
11/15/2001	US20010041720 2-Amino-N-((1R)-2-((3R)-3-benzyl-3-(N,N',N' -trimethylhydrazinocarbonyl)piperidin-1-yl)-1-(1H-indol-3-ylmethyl)-2 -oxoethyl)-2-methylpropionamide; increasing rate and extent of growth, milk and wool production
11/15/2001	US20010041719 The use of R (+)-alpha- (2,3-Dimethoxyphenyl) -1- [ 2- (4-fluorophenyl) ethyl] -4-piper idinemethanol for the treatment of sleep disorders
11/15/2001	US20010041710 (4R)-1-(4-(4-Fluorophenoxy)benzyl)-2-oxo-imidazolidine-4 -carboxylic acid hydroxyamide, for example; treating various diseases including osteoarthritis, rheumatoid arthritis, cancer, osteoporosis, strokes
11/15/2001	US20010041685 Mucin synthesis inhibitors
11/15/2001	US20010041682 Purine or pyrimidine containing dinucleotide derivatives useful for hydrating mucous secretions in the lungs of a patient in need of such a treatment
11/15/2001	US20010041189 Dipeptide containing glutamic acid
11/15/2001	US20010041178 Preventing airway mucus production by administration of EGF-R antagonists
11/15/2001	US20010041164 Pharmaceutical preparation for inhalation of an opioid
11/15/2001	CA2409759A1 Method and composition for the treatment of angiogenesis
11/15/2001	CA2408751A1 2-substituted pregna-1, 3, 5 (10) -triene and chola-1, 3, 5 (10)-triene derivatives and their biological activity

1 ... 692 693 694 695 696 697 698 699 700 701 702 703 704 705 706 707 708 709 710 711 712 ... 878